NO20031650L - Nye legemidler for leversykdommer - Google Patents

Nye legemidler for leversykdommer

Info

Publication number
NO20031650L
NO20031650L NO20031650A NO20031650A NO20031650L NO 20031650 L NO20031650 L NO 20031650L NO 20031650 A NO20031650 A NO 20031650A NO 20031650 A NO20031650 A NO 20031650A NO 20031650 L NO20031650 L NO 20031650L
Authority
NO
Norway
Prior art keywords
liver diseases
new medicines
medicines
new
liver
Prior art date
Application number
NO20031650A
Other languages
English (en)
Other versions
NO20031650D0 (no
Inventor
Egashira Kensuke
Akira Takeshita
Masamichi Koyanagi
Makoto Nakamuta
Ken-Ishi Nishida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20031650D0 publication Critical patent/NO20031650D0/no
Publication of NO20031650L publication Critical patent/NO20031650L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031650A 2000-10-11 2003-04-10 Nye legemidler for leversykdommer NO20031650L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000310604 2000-10-11
PCT/JP2001/008552 WO2002030464A1 (en) 2000-10-11 2001-09-28 Novel drugs for liver diseases

Publications (2)

Publication Number Publication Date
NO20031650D0 NO20031650D0 (no) 2003-04-10
NO20031650L true NO20031650L (no) 2003-06-05

Family

ID=18790533

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031650A NO20031650L (no) 2000-10-11 2003-04-10 Nye legemidler for leversykdommer

Country Status (8)

Country Link
US (1) US7335647B2 (no)
EP (1) EP1325751A4 (no)
JP (1) JPWO2002030464A1 (no)
CN (1) CN1469756A (no)
AU (1) AU2001292301A1 (no)
CA (1) CA2425765A1 (no)
NO (1) NO20031650L (no)
WO (1) WO2002030464A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60139944D1 (de) 2000-10-12 2009-10-29 Genentech Inc Niederviskose konzentrierte proteinformulierungen
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
EP1447095B1 (en) * 2001-11-02 2012-06-13 Kensuke Egashira Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
CA2507008A1 (en) * 2002-12-23 2004-07-29 Applied Research Systems Ars Holding N.V. Use of cc-chemokine mutants against liver diseases
PT1610820E (pt) 2003-04-04 2010-12-16 Novartis Ag Formulações de elevada concentração de anticorpos e proteínas
BRPI0718225A2 (pt) * 2006-10-05 2013-11-12 Centocor Ortho Biotech Inc Antagonistas de ccr2 para tratamento de fibrose
KR20090083902A (ko) * 2006-10-12 2009-08-04 노파르티스 아게 개질된 사이클로스포린의 용도
PE20120359A1 (es) 2009-03-06 2012-04-13 Genentech Inc Formulacion con anticuerpo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5459128A (en) * 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
JP3720861B2 (ja) 1994-10-21 2005-11-30 帝人株式会社 プロスタグランジン類およびその製造法
GB9501683D0 (en) 1995-01-27 1995-03-15 Glaxo Group Ltd Substances and their uses
JPH0967399A (ja) * 1995-08-30 1997-03-11 Mitsui Toatsu Chem Inc 抗ｍｃｐ−１ヒトモノクローナル抗体
US6184235B1 (en) * 1996-08-14 2001-02-06 Warner-Lambert Company 2-phenyl benzimidazole derivatives as MCP-1 antagonists
GB9716656D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
JPH1160502A (ja) 1997-08-12 1999-03-02 Teijin Ltd 脳梗塞症治療薬もしくは予防薬
JP2000239182A (ja) 1999-02-19 2000-09-05 Mitsubishi Chemicals Corp 抗炎症剤

Also Published As

Publication number Publication date
NO20031650D0 (no) 2003-04-10
AU2001292301A1 (en) 2002-04-22
EP1325751A4 (en) 2005-05-04
US7335647B2 (en) 2008-02-26
CN1469756A (zh) 2004-01-21
US20050053603A1 (en) 2005-03-10
CA2425765A1 (en) 2003-04-11
JPWO2002030464A1 (ja) 2004-02-19
EP1325751A1 (en) 2003-07-09
WO2002030464A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
KR20050009999A (ko) 약제학적 제제
NO20030418L (no) Nytt farmasöytisk preparat
EE200300416A (et) Ravimvorm
NO20071303L (no) Farmasoytiske preparater
DK1524266T3 (da) Farmaceutisk sammensætning
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20026064L (no) Nye forbindelser
NO20023933L (no) Nye forbindelser
NO20033556D0 (no) Farmasöytiske preparater
FI20011478A0 (fi) Farmaseuttinen koostumus
PT1501534E (pt) Formulacoes farmaceuticas
NO20034970D0 (no) Nye arylheteroalkylaminderivater
NO20020810L (no) Nye fenylpiperaziner
MXPA03001425A (es) Compuestos farmaceuticos.
NO20025151D0 (no) Nye forbindelser
NO20031141D0 (no) Nye forbindelser
DE60105724D1 (de) Stanzmutter
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20014926L (no) Farmasöytiske forbindelser
NO20026162L (no) Nye forbindelser
NO20015651D0 (no) Nye farmasöytiske kombinasjoner for NOS inhibitorer
DK1331972T3 (da) Farmaceutiske præparater
ITMI20001827A0 (it) Medicamento antinfiammatorio
NO20030274L (no) Nye aryleten-sulfonamider
NO20026081D0 (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application